BioHarvest Advances Proprietary Olive Cell Asset to Commercial Readiness, Opening New CDMO Licensing Opportunity

Go back to BioHarvest Advances Proprietary Olive Cell Asset to Commercial Readiness, Opening New CDMO Licensing Opportunity
(NASDAQ: BHST) Delayed: 1.68 +0.01 (0.60%)
Previous Close $1.67    52 Week High $ 
Open $1.67    52 Week Low $ 
Day High $1.78    P/E N/A 
Day Low $1.63    EPS $ 
Volume 13,252